Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
iTeos Therapeutics Inc. logo

iTeos Therapeutics Inc.

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

13.17
 
USD
  
0.82
  
(6.64%)
Optionable: Yes  Market Cap: 443 M  90-day average vol: 257,048

Previous close: 12.35  Open: 12.73  Bid: 13.17  Ask: 13.99
52 week range    
8.20   
   18.24
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Thursday 28th March 2024
54
MarketXLS Rank
60
Value
76
Technical
28
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ITOS Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
AccretionOnPreferredStock5 M
AccruedPreferredStockDividends249000.0
AcquiredInProcessRnD286000.0
Basic EPS from continuing operations6.12.72-3.15
Basic EPS total-2.886.12.72-3.15
Basic weighted shares outstanding15 M35 M36 M36 M
Depreciation600000.0800000.0900000.0
Depreciation unreconciled-500000.0
DepreciationAndAmortization-500000.0600000.0800000.0900000.0
Diluted EPS total-2.885.682.56-3.15
Diluted normalized net income/share5.682.56-3.15
Diluted weighted shares outstanding15 M38 M38 M36 M
GeneralAndAdministrativeExpense15 M41 M44 M50 M
Gross operating profit345 M268 M13 M
Income before tax-38 M256 M149 M-109 M
Income taxes-57000.042 M52 M4 M
Interest income78000.011 M32 M
MiscOtherSpecialCharges-48000.01 M8 M4 M
Net income from total operations-39 M215 M97 M-113 M
NetIncomeCommonStockholders-45 M215 M97 M-113 M
NetIncomeContinuousOperations-39 M215 M97 M-113 M
NetNonOperatingInterestIncomeExpense6 M78000.011 M32 M
Normalized income203 M-86 M
Operating income-45 M245 M126 M-151 M
Operating income before depreciation (EBITDA)-38 M257 M150 M-108 M
OperatingExpense-45 M100 M141 M164 M
Other income net-6 M-1 M-8 M-4 M
OtherGandA15 M41 M44 M50 M
OtherOperatingExpenses-17 M-22 M-2 M
OtherunderPreferredStockDividend5 M
PreferredStockDividends5 M
RealizedCapitalGain6 M
RentAndLandingFees15 M700000.0900000.01 M
Research & development expense30 M59 M97 M113 M
ResearchExpense30 M59 M97 M113 M
SalariesAndWages-4 M
Selling Gen & administrative expense15 M41 M44 M50 M
Special income/charges286000.0
Total Income available for interest expense (EBIT)-38 M256 M149 M-109 M
Total common shares outstanding35 M36 M36 M
Total net income-39 M215 M97 M-113 M
Total ordinary shares36 M36 M36 M36 M
Total revenues345 M268 M13 M
TotalExpenses-45 M100 M141 M164 M
TotalRevenue345 M268 M13 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University